Are nutritional supplements ready for prime time?

Journal of Clinical Psychiatry

Volumn 69, Issue 9, 2008, Pages 1497-1498

  Mischoulon, David ^a   Fava, Maurizio ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; DEPLIN; FOLIC ACID; HYPERICUM PERFORATUM EXTRACT; OMEGA 3 FATTY ACID; PLACEBO; S ADENOSYLMETHIONINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

BLEEDING; CLINICAL TRIAL; DEMENTIA; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FOLIC ACID DEFICIENCY; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR DEPRESSION; MONOTHERAPY; PRESCRIPTION; PRIORITY JOURNAL; SEROTONIN SYNDROME; SHORT SURVEY; UNSPECIFIED SIDE EFFECT;

EID: 52649152593     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v69n0918     Document Type: Short Survey

References (22)

1. Mischoulon D, Fava M. Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. Am J Clin Nutr 2002 Nov;76(5):1158S-1161S
2. Papakostas GI, Alpert JE, Fava M. S-adenosyl-methionine in depression: a comprehensive review of the literature. Curr Psychiatry Rep 2003 Dec;5(6):460-466
3. Linde K, Mulrow CD, Berner M, et al. St John's wort for depression. Cochrane Database Syst Rev 2005 Apr;(2):CD000448
4. Mischoulon D. Update and critique of natural remedies as antidepressant treatments. Psychiatr Clin North Am 2007 Mar;30(1):51-68
5. Freeman MP, Hibbeln JR, Wisner KL, et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 2006;67(12):1954-1967
6. Mischoulon D, Raab MF. The role of folate in depression and dementia. J Clin Psychiatry 2007;68(suppl 10):28-33
7. Alpert JE, Papakostas G, Mischoulon D, et al. S-adenosyl- L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine. J Clin Psychopharmacol 2004 Dec;24(6):661-664
8. Taylor MJ, Carney SM, Goodwin GM, et al. Folate for depressive disorders: systematic review and meta-analysis of randomized controlled trials. J Psychopharmacol 2004 Jun;18(2):251-256
9. Coppen A, Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. J Affect Disord 2000 Nov;60(2):121-130
10. Alpert JE, Mischoulon D, Rubenstein GEF, et al. Folinic acid (leucovorin) as an adjunctive treatment for SSRI-refractory depression. Ann Clin Psychiatry 2002;14:33-38
11. Passeri M, Cucinotta D, Abate G, et al. Oral 5′- methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter study. Aging (Milano) 1993;5:63-71
12. Mischoulon D, Dording C. Polypharmacy, side effect management, and drug-drug interactions with natural psychotropic medications and acupuncture. In: Mischoulon D, Rosenbaum J, eds. Natural Medications for Psychiatric Disorders: Considering the Alternatives, 2nd ed. Philadelphia, Pa: Lippincott Williams & Wilkins. In press
13. Alpert JE, Papakostas GI, Mischoulon D. One-carbon metabolism and the treatment of depression: roles of S-adenosyl-L-methionine and folate. In: Mischoulon D, Rosenbaum J, eds. Natural Medications for Psychiatric Disorders: Considering the Alternatives, 2nd ed. Philadelphia, Pa: Lippincott Williams & Wilkins. In press
14. Khan A, Khan S, Brown WA. Are placebo controls necessary to test new antidepressants and anxiolytics? Int J Neuropsychopharmacol 2002 Sep;5(3):193-197
15. Kirsch I, Deacon BJ, Huedo-Medina TB, et al. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 2008 Feb;5(2):e45
16. Mischoulon D. Nutraceuticals in psychiatry, pt 1: social, technical, economic, and political perspectives. Contemporary Psychiatry 2004;2(11):1-6
17. Eisenberg DM, Kessler RC, Foster C, et al. Unconventional medicine in the United States: prevalence, costs, and patterns of use. N Engl J Med 1993;328:246-252
18. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998 Nov;280(18):1569-1575
19. Business Report 2007. Nutr Business J 2007;Oct(suppl):666 20. Mischoulon D, Rosenbaum JF. The use of natural medications in psychiatry: a commentary. Harv Rev Psychiatry 1999;6:279-283
20. Lee JH, O'Keefe JH, Lavie CJ, et al. Omega-3 fatty acids for cardioprotection. Mayo Clin Proc 2008 Mar;83(3):324-332
21. Bentley TG, Weinstein MC, Willett WC, et al. A cost-effectiveness analysis of folic acid fortification policy in the United States. Public Health Nutr [published online ahead of print July 1, 2008]. doi:10.1017/ S1368980008002565
22. Najm WI, Reinsch S, Hoehler F, et al. S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial [ISRCTN36233495]. BMC Musculoskelet Disord 2004 Feb;5:6